Kinase Inhibitors

M2698 View larger

NVP-LXS196

AOB33606

CAS: 1874276-76-2

 

Chemical Name: Darovasertib; LXS196; IDE196; 3-Amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide

More details

Molarity Calculation Cart®

HOW TO ORDER

$37.00

$37.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $16.65 Total: $1,665.00
150 $19.24 Total: $962.00
125 $22.57 Total: $564.25
110 $26.64 Total: $266.40
15 $31.45 Total: $157.25

Data sheet

Molecular FormulaC22H23F3N8O
Molecular Weight472.48
CAS Numbers1874276-76-2
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymNVP-LXS196; NVPLXS196; NVP LXS196; LXS-196; LXS 196; LXS196; LXS-196 free base
IUPAC/Chemical Name3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide
InChl KeyXXJXHXJWQSCNPX-UHFFFAOYSA-N
InChl CodeInChI=1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34)
SMILES CodeNC1=C(C(NC2=C(N3CCC(C)(N)CC3)C=CC=N2)=O)N=C(C4=NC=CC=C4C(F)(F)F)C=N1
References1) Shaheer Khan et al., Novel Approaches to the Systemic Management of Uveal Melanoma, Current Oncology Reports volume 22, Article number: 104 (2020)

More info

Novel orally available protein kinase C (PKC) inhibitor, preventing the activation of PKC-mediated signaling pathways